GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

Lanini S;Capone S;Antinori A;Milleri S;Nicastri E;Camerini R;Agrati C;Castilletti C;Mori F;Sacchi A;Matusali G;Gagliardini R;Ammendola V;Cimini E;Grazioli F;Scorzolini L;Napolitano F;Plazzi MM;Soriani M;De Luca A;Battella S;Sommella A;Contino AM;Barra F;Gentile M;Raggioli A;Shi Y;Girardi E;Maeurer M;Capobianchi MR;Vaia F;Piacentini M;Kroemer G;Vitelli A;Colloca S;Folgori A;Ippolito G;Ottou S;Vita S;Vergori A;D'Abramo A;Petrecchia A;Montaldo C;Scalise E;Grassi G;Casetti R;Bordoni V;Notari S;Colavita F;Meschi S;Lapa D;Bordi L;Murachelli S;Tambasco T;Grillo A;Masone E;Marchioni E;Bardhi D;Porzio O;Cocca F;Murachelli S;Turrini I;Malescio F;Ziviani L;Lawlor R;Poli F;Martire F;Zamboni D;Mazzaferri F.

2021-01-01